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ABSTRACT
Gonorrhoea is one of the most common sexually transmitted infections (STIs) in developing countries, 
and the emergence of resistance to antimicrobial agents in Neisseria gonorrhoeae is a major obstacle in the 
control of gonorrhoea. Periodical monitoring of antimicrobial susceptibility of N. gonorrhoeae is essential 
for the early detection of emergence of drug resistance. In total, 1,767 gonococcal strains isolated from 
males and females (general population and those with high-risk behaviour) from different parts of Bangla-
desh were studied during 1997-2006. Minimum inhibitory concentrations of penicillin, tetracycline, cipro-
floxacin, ceftriaxone, spectinomycin, and azithromycin for the isolates were determined by the agar dilu-
tion method. Isolates resistant to three or more antimicrobial agents are considered multidrug-resistant. 
The prevalence of plasmid-mediated penicillinase-producing N. gonorrhoeae (PPNG) and plasmid-mediated 
tetracycline-resistant N. gonorrhoeae (TRNG) was determined. Nine percent of the isolates were resistant 
to ciprofloxacin in 1997 compared to 87% in 2006. Multidrug-resistant N. gonorrhoeae have emerged in 
1997, and 44% of the strains (n=66) isolated during 2006 were multidrug-resistant. Forty-two percent of 
the isolates in 2006 were both PPNG- and TRNG-positive compared to none in 1997. The rapidly-changing 
pattern of gonococcal antimicrobial susceptibility warrants the need for an antimicrobial susceptibility-
monitoring programme, and periodical analysis and dissemination of susceptibility data are essential to 
guide clinicians and for successful STI/HIV intervention programmes.  
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INTRODUCTION
Gonorrhoea is one of the classical sexually transmit-
ted infections (STIs) with humans as the only host 
for the causative agent Neisseria gonorrhoeae. Des- 
pite a sharp decline in the incidence of gonococ-
cal infection in developed countries during the last 
decade, gonorrhoea still remains one of the most 
common STIs in developing countries and a global 
health problem (1). The prevalence of gonococcal 
infection varies greatly among countries in the de-
veloped and developing world, the highest be-
ing in South and Southeast Asia, followed by sub- 
Saharan Africa and Latin America, where it contin-
ues to be a major public-health problem. According   
to  the World Health Organization (WHO), there are 
approximately 62 million new  cases  of gonorrhoea 
worldwide annually, and almost half of the cases   
are estimated to occur in Southeast Asia, including 
Bangladesh (2). Ahmed MU et al. Antimicrobial susceptibility of N. gonorrhoeae in Bangladesh
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In the absence of any effective vaccine against N. 
gonorrhoeae, control of gonococcal infection main-
ly depends on the identification and treatment of 
infected individuals. An early and successful anti- 
biotic treatment of gonococcal infection is impor-
tant for cure of the individual patient, preven-
tion of complications, and reduction of transmis-
sion (3). Strategies for the control of gonorrhoea 
have relied on the use of highly-effective and often 
single-dose therapy administered at the time of di-
agnosis (4). Information on antimicrobial suscep-
tibility of N. gonorrhoeae is, therefore, important for 
the selection of an appropriate antimicrobial agent 
(5). 
The versatile nature of the gonococcus and its ca-
pacity to cope with changing conditions in micro-
environment is a major challenge in the preven-
tion and control of gonococcal infection (6). The 
continuous emergence of resistance to antimi-
crobial agents has made the treatment of gonor-
rhoea expensive, prolonged, and unpredictable. 
The organism acquires resistance by spontane-
ous mutation or by acquisition of new DNA via 
conjugation or transformation, and resistance 
may, thus, be chromosomal or plasmid-mediated 
(7). A single organism can have both the mecha-
nisms of resistance, and resistance to multiple 
antibiotics is often common (8,9).  
The ability of N. gonorrhoeae to become resistant 
to cheap and effective antimicrobial agent is well- 
recognized since the introduction of sulphona-
mide. Due to change in gonococcal antimicrobial   
susceptibility pattern and the emergence of peni-
cillinase-producing N. gonorrhoeae (PPNG), plas-
mid-mediated tetracycline-resistant N. gonorrhoeae 
(TRNG) and chromosomally-mediated resistance 
to penicillin and tetracycline in N. gonorrhoeae (CM-
RNGPT), and continuing development of fluoroqui-
nolone resistance, the Centers for Disease Control 
and Prevention (CDC), Atlanta, GA, USA, recom-
mends third-generation cephalosporins as the first-
line therapy for uncomplicated gonorrhoea (10). 
Antimicrobial resistance in gonococci often spreads 
rapidly among countries, and infected travellers of-
ten appear for treatment in countries distant from 
the source of infection (11). Hence, data on local 
and regional antimicrobial resistance are impor-
tant for the management and treatment of gonor-
rhoea. 
In Bangladesh, the national STI-management 
guideline recommended the use of ciprofloxacin as 
the first-line therapy for the treatment of uncom- 
plicated gonococcal infection during 1997-2006, 
and there was no systematic antimicrobial suscep-
tibility surveillance for N. gonorrhoeae in the coun-
try. International Centre for Diarrhoeal Disease 
Research, Bangladesh (ICDDR,B) had initiated the 
antimicrobial susceptibility monitoring for N. gon-
orrhoeae in Dhaka, the capital of Bangladesh, since 
1997, and it was subsequently extended to three 
major cities (Chittagong, Jessore, and Sylhet). We 
report the antimicrobial susceptibility of N. gon-
orrhoeae in Bangladesh during 1997-2006 and, in 
particular, the emergence and spread of multidrug-
resistant N. gonorrhoeae in Bangladesh. 
MATERIALS AND METHODS
Bacterial strain 
All N. gonorrhoeae strains isolated from both male 
and female subjects from Dhaka and six major ci- 
ties (Chittagong, Sylhet, Faridpur, Mymensingh, Ba-
risal, and Jessore) of Bangladesh during 1997-2006 
were studied. Isolates were collected as part of STI 
service-delivery programmes (for female sex work-
ers in Dhaka and Jessore and for male having sex 
with male and male STI patients in Chittagong and 
Sylhet) established by ICDDR,B during 1997-2003 
or as part of different STI epidemiological studies 
conducted during 1997-2006 in Dhaka, Jessore, 
Faridpur, Sylhet, Mymensingh, Chittagong, and 
Barisal. Isolates of N. gonorrhoeae were grown on 
modified Thayer-Martin medium (MTM) and incu-
bated overnight at 37 0C with 5-10% CO2. All the 
isolates were identified as N. gonorrhoeae using con-
ventional procedures, including colony morpho- 
logy, Gram-staining, oxidase and catalase tests, 
and carbohydrate-use test. Isolates were stored at 
-86 0C in tryptic soy-broth (TSB) with 20% glyce- 
rol until further study.
Minimum inhibitory concentrations
Minimum inhibitory concentrations (MICs) to 
penicillin, tetracycline, ciprofloxacin, ceftriaxone,   
spectinomycin, and azithromycin were deter-
mined by an agar dilution method described ear-
lier (12,13). The breakpoint criteria defined by the 
National Committee for Clinical Laboratory Stand-
ards (NCCLS) were used for penicillin, tetracycline, 
ciprofloxacin, ceftriaxone, and spectinomycin,   
and the breakpoint  criteria used for azithromycin 
were MIC of ≤0.25 µg/mL for susceptible, ≥0.5 of 
µg/mL for reduced susceptible, and ≥1 of µg/mL 
for resistance. Two-fold serial dilutions of antibi-
otics were used: penicillin (Sigma, St. Louis, MO) 
0.06-32 µg/mL, tetracycline (Sigma, St. Louis, MO)   
0.25-64 µg/mL, ciprofloxacin (Bayer, Hampshire, 
United Kingdom) 0.004-32.0 µg/mL, ceftriaxone 
(Sigma) 0.004-1.0 µg/mL, spectinomycin (Upjohn, 
Puurs, Belgium) 8.0-128 µg/mL, and azithromy-
cin (Pfizer Inc., Connecticus, USA) 0.008-1 µg/mL. 
Briefly, confluent overnight culture of N. gonor-
rhoeae was suspended in TSB and adjusted to Mc-
Farland turbidity 0.5. Ten microlitre of the bacte-Ahmed MU et al. Antimicrobial susceptibility of N. gonorrhoeae in Bangladesh
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rial suspension (1x104 cfu) was spotted on GC agar 
(Oxoid Ltd, Basingstoke, Hampshaire, UK) plates as 
recommended by the WHO, containing two-fold 
serial dilution of antimicrobial agents using a multi-
point inoculator (Mast Diagnostic Ltd., SCAN 114). 
The quality control of the MIC test was ensured 
by including seven N. gonorrhoeae reference strains 
WHO A, B, C, D, E, G, and H with known MICs 
in each test, by repeating each test three times and 
by participating in the WPRO/SEARO GASP (West-
ern Pacific Region Office/South-East Asia Regional 
Office/Gonococcal Antimicrobial Surveillance Pro-
gramme) external quality-assurance programme 
(our data were in agreement with expected results 
for all antimicrobial agents during the study pe-
riod).  
Plasmid typing for PPNG and TRNG isolates
The plasmid type for the PPNG isolates was deter-
mined by PCR detection of β-lactamase-producing 
plasmid as described earlier (14), and the plasmid 
type for the TRNG isolates was determined by PCR 
amplification of tetM gene in 25.2-MDa conjuga-
tive plasmid (15). The primers for PPNG were de-
signed to identify and distinguish Asia (7426)-, 
Africa (5599)-, and Toronto (5154)-type plasmid 
generating 4.9 kb, 3.1 kb, and 2.6 kb amplicons res- 
pectively. The primers for TRNG were designed to 
identify and distinguish American and Dutch-type 
plasmids generating amplicon of 1600 bp and 700 
bp respectively. PCR was carried out with boiled 
whole-cell suspension (1x108. CFU/mL) of N. gonorr 
hoeae grown overnight on MTM plate (14,15). 
Phenotypic characterization
The criteria used for phenotypic characterization of 
N. gonorrhoeae were based on plasmid- and chromo-
somally-mediated resistance to penicillin and tetra-
cycline as described earlier (16). Isolates resistant to 
three or more antimicrobial agents were considered 
multidrug-resistant N. gonorrhoeae.
RESULTS
In total, 1,767 gonococcal isolates were collected 
from males and females (population with high-risk 
behaviour and general population) from different 
parts of the country during 1997-2006. In 1997, the 
antimicrobial susceptibility-monitoring programme 
for N. gonorrhoeae was introduced in Dhaka, the 
capital of Bangladesh, and was later (1999-2003) 
extended to three major cities (Chittagong, Jessore, 
and Sylhet), in southeast, southwest and northeast 
parts of Bangladesh respectively. The programme 
was part of the STI service-delivery programme 
established by ICDDR,B. During 2004-2006, the 
programme was implemented only in Dhaka. Be-
sides this, N. gonorrhoeae isolates from different epi-
demiological studies conducted during 1997-2006 
in Dhaka, Jessore, Faridpur, Mymensingh, and Ba-
risal were also included in the study. The number, 
source, and year of isolation are shown in Table 1.  
The MICs of penicillin, tetracycline, ciprofloxacin, 
ceftriaxone, spectinomycin, and azithromycin for 
all the isolates were determined. The antimicrobial 
susceptibility (resistant and reduced susceptible) of 
the isolates to penicillin, tetracycline, and cipro-
floxacin during 1997-2006 are shown in Fig. 1 (a, 
b, and c). Approximately 9% of the isolates in 1997 
were resistant to ciprofloxacin compared to 87% 
in 2006 with the highest (92%) resistance in 2003. 
Table 1. Year and source of Neisseria gonorrhoeae strains isolated from different population groups 
in different parts of Bangladesh during 1997-2006
Year
Total 
isolates
(n=1,767)
No of isolates from different population groups
FSW
(n=982)
BBSW
(n=103)
HBSW
(n=225)
MSM
(n=30)
MT
(n=81
MSTI
(n=270)
FSTI
(n=76)
1997 131 941 301,7 0 0 0 0 71
1998 65 651 0 0 0 0 0 0
1999 131 1021 297 0 0 0 0 0
2000 210 2081 0 0 0 0 0 21
2001 147 1331 0 0 52 81 11 0
2002 476 661 224 1481 151,2,3 341 1531,2,3,4 381,2,3
2003 340 1241 225 0 101,2,3 391 1161,2,3,4 292,3
2004 90 901 0 0 0 0 0 0
2005 111 521 595,6 0 0 0 0 0
2006 66 481 185
BBSW=Brothel-based female sex worker; FSTI=Female STI patients; FSW=Street-based female sex 
workers; HBSW=Hotel-based sex workers; MSM=Male having sex with male; MSTI=Male STI pa-
tients; MT=Male truckers; STI=Sexually transmitted infection; Isolates from 1Dhaka, 2Chittagong, 
3Sylhet, 4Jessore, 5Faridpur, 6Barisal, and 7MymensinghAhmed MU et al. Antimicrobial susceptibility of N. gonorrhoeae in Bangladesh
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Fig. 2. Prevalence  of  PPNGi, TRNGand 
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Fig. 1. The prevalence of antimicrobial susce-
           ptibility (resistance and reduced susc-
           eptible    ) to penicillin, tetracycline,
           and ciproﬂoxacin of Neisseria gonorrho-
          eae isolates from Bangladesh during
           1997-2006
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All the isolates were susceptible to ceftriaxone, azi-
thromycin (MIC of ≤1 µg/mL), and spectinomycin, 
except that one isolate (0.2%) in 2002 and one 
each isolate in 2003, 2005, and 2006 were resistant 
to azithromycin and spectinomycin respectively. 
The MIC at which 50% and 90% of the isolates 
were inhibited (MIC50 and MIC90 respectively) 
was determined for each year (Table 2). Although 
most isolates in the present study were susceptible 
to azithromycin, a gradual increase in MIC of azi-
thromycin was observed during 2003-2006 (Table 
2). While none of the isolates had an MIC of ≥0.25 
µg/mL in 1997, approximately 25% of the isolates 
from 2003 had an MIC of ≥0.25 µg/mL for azithro-
mycin. No significant difference in resistance was 
observed among isolates collected from different 
populations and cities in a given year. 
The presence of PPNG and TRNG among the iso-
lates was determined by PCR. Approximately 14% 
of the isolates were PPNG in 1997 compared to 44% 
in 2006. Of the isolates from 1997, 20% were TRNG 
compared to 86% in 2006. None of the isolates was 
both PPNG and TRNG in 1997 and 1998 compared 
to 42% in 2006 (Fig. 2). 
More than 90% of the isolates from 1997 to 2006 
carried 3.2-MDa African type PPNG plasmid. How-
ever, 4.5% (8/175) and 4.5% (5/131) of the PPNG 
isolates of 2002 and 2003 respectively carried a 
Toronto-type plasmid respectively. Of the TRNG 
isolates, 11% (2/18), 2% (1/49), 7.5% (9/119), 3.2% Ahmed MU et al. Antimicrobial susceptibility of N. gonorrhoeae in Bangladesh
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(6/186), and 2% (5/252) in 1998, 1999, 2000, 2002,   
and 2003 carried 1600-bp American type tetM gene 
in the 25.2-MDa conjugative plasmid respective-
ly, and the remaining TRNG isolates carried 700 
Dutch type tetM gene in the 25.2-MDa conjugative 
plasmid (data not shown). 
The prevalence of isolates resistant to three or more 
antimicrobial agents during 1997-2006 was further 
determined. Six percent, 27%, 16%, 43%, 50%, 
40%, 42%, 51%, 47%, and 44% of the isolates in 
1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004,   
2005, and 2006 respectively were resistant to three 
or more antimicrobial agents. Of the multidrug-
resistant isolates, none was both PPNG and TRNG 
in 1997 and 1998, and 33% (10/21), 62% (66/92), 
61% (54/74), 66% (128/193), 64% (93/145), 59% 
(27/46), 63% (32/53), and 83% (24/29) of the 
isolates from 1999, 2000, 2001, 2002, 2003, 2004, 
2005, and 2006 were both PPNG and TRNG respec-
tively. One multidrug-resistant isolate from 2002 
was both PPNG and TRNG and was resistant to cip-
rofloxacin and azithromycin. Similarly, one multi-
drug-resistant isolate from 2003 and one from 2005 
were both PPNG and TRNG and were also resistant 
to ciprofloxacin and spectinomycin. 
DISCUSSION
The control of gonococcal infection is impor-
tant considering the high incidence of acute 
infections, complications, and sequelae and its 
role in facilitating acquisition and transmission 
of HIV (17,18). The knowledge of antimicrobial 
susceptibility of N. gonorrhoeae is a prerequisite 
for the proper treatment and control of gonococ-
cal infection. A regional programme for moni-
toring gonococcal antimicrobial susceptibility 
has been established in developed countries, such 
as the USA, Canada, Australia, and The Nether- 
lands. However, in developing countries where 
the burden of disease is high and the resistance is 
the greatest, such activity rarely exists (2,19-21). In 
Bangladesh, there was no established antimicro-
bial susceptibility surveillance for N. gonorrhoeae. 
In the absence of laboratory data and an estab-
lished monitoring system, selection of appropri-
ate antimicrobials for the empirical treatment 
of gonorrhoea is difficult. We initiated the anti-
microbial susceptibility surveillance in Dhaka in 
1997, and subsequently, the surveillance was ex-
tended to three major cities.  
We examined 1,767 gonococcal isolates cultured 
from street-based, brothel-based, hotel-based fe-
male sex workers, male STI patients, male having 
sex with male (MSM) population, male truckers, 
and male and female STI patients during 1997-
2006. Although the incidence of gonococcal Ahmed MU et al. Antimicrobial susceptibility of N. gonorrhoeae in Bangladesh
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infection among males and females with high-risk 
behaviour and from general population in Bang-
ladesh is not known, the isolates could be reason-
ably considered to be representative of gonococcal 
strains in the country based on the fact that the iso-
lates tested in the study were cultured from differ-
ent high-risk population and from different parts 
of the country.
A rapid increase in resistance to ciprofloxacin was 
observed during the study. Such increase in resist-
ance has been documented in some Western pacif-
ic countries, such as in China (85.2%), Hong Kong 
(79.5%, The Philippines (37.9%), and Viet Nam 
(42.7%) (2). Ciprofloxacin has been extensively 
used in Bangladesh for the treatment of suspected 
gonorrhoea as it is relatively cheap and effective,   
and only a single oral dose is required. As a conse-
quence of the long-time and large-scale use of this 
group of antimicrobial agents in areas where over-
the-counter availability of drugs without prescrip-
tion is common, a substantial increase in resistant 
strains may occur (22). Data from the present study 
seem to reflect the consequence of the long-stand-
ing usage of ciprofloxacin for the treatment of sus-
pected gonorrhoea using syndromic management 
at STI clinics in Bangladesh. 
Resistance to penicillin and tetracycline may 
be either chromosomally-mediated or plasmid- 
mediated. Chromosomally-mediated resistance to 
penicillin is of low-level resistance and results from 
additive effect of mutations at multiple loci, includ-
ing penA, mtr, and penB while plasmid-mediated 
resistance is due to PPNG encoding a TEM-1 type 
β-lactamase. Approximately half of the isolates dur-
ing the study were resistant to penicillin. Of the 
penicillin-resistant isolates, the prevalence of PPNG 
increased from 28% to 88% during 1997-2006. Re-
sults of plasmid analysis showed that most isolates 
carried an African type plasmid; however, isolates 
carrying Toronto-type plasmid were introduced in 
2002, and there was a steady increase since then. 
All the isolates carrying Toronto-type PPNG plas-
mid during 2002 were isolated from long-distance 
truck-divers, and in 2003, isolates carrying Toronto-
type PPNG plasmid were isolated from sex workers 
in Dhaka. This might be due to acquisition of N. 
gonorrhoeae clone with Toronto-type PPNG plasmid 
by long-distance truckers and subsequent trans-
mission to sex workers. 
Although more than three-fourths of the isolates 
were resistant to tetracycline, it is not currently 
used for the treatment of gonorrhoea in Bangla-
desh. This might be due to the fact that tetracycline 
is used for many other illnesses, and doxycycline is 
still used for the treatment of Chlamydia-associated 
infection in Bangladesh. High-level plasmid-medi-
ated resistance to tetracycline is due to the acqui-
sition of tetM gene by the conjugative plasmid of 
N. gonorrhoeae, resulting in a 25.2-MDa plasmid. 
Tetracycline-resistant N. gonorrhoeae isolates are 
likely to spread more quickly than PPNG isolates 
because of the presence of tetM plasmid in other 
flora found in the genital tract that may act as a 
reservoir. Of the tetracycline-resistant isolates, the 
prevalence of TRNG increased from 30% to 95% 
during 1997-2006. The increase in the prevalence 
of both PPNG and TRNG isolates might be due to 
acquisition of penicillinase plasmid in the TRNG 
isolates as transfer of penicillinase plasmid requires 
the presence of conjugative plasmid (23).  
The most striking finding of the present study is 
the emergence of isolates resistant to three or more 
antimicrobial agents. More than half of the isolates 
are resistant to three drugs, including ciprofloxacin, 
the first-line therapy for gonorrhoea. Of the multi-
drug-resistant isolates, more then half were both 
PPNG and TRNG. Besides this, isolates resistant to 
four antimicrobial agents have also been identi-
fied. 
Antimicrobial susceptibility data play a major role 
in updating or revising the national guideline for 
the management of STIs. Based on our surveillance 
data, the National AIDS and STD Programme, Min-
istry of Health and Family Welfare, Government 
of Bangladesh, has revised the national guidelines 
for the management of STIs in 2007 and recom-
mended cefixime as the first-line therapy for gono- 
rrhoea. The current alternatives to quinolones for 
gonococcal infection are the extended spectrum or 
third-generation cephalosporins. All the isolates in 
the present study were susceptible to ceftriaxone 
and cefixime. 
Considering the rapidly-changing pattern of gono-
coccal antimicrobial susceptibility, it is important 
to maintain the antimicrobial susceptibility-moni- 
toring programme, periodical analysis of suscepti-
bility data, and updating the treatment guidelines 
for successful STI/HIV intervention programmes.  
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